Literature DB >> 11777837

Immunoglobulin E antileishmanial antibody response in cutaneous leishmaniasis.

Maria L B Sousa-Atta1, Gregório S Salamé, Argemiro D'Oliveira, Roque P Almeida, Ajax M Atta, Edgar M Carvalho.   

Abstract

High levels of antileishmanial immunoglobulin E (IgE) antibodies are associated with disease activity in visceral leishmaniasis. Herein, we report our observations about the relationship between antileishmanial IgE antibodies and clinical aspects of cutaneous leishmaniasis. This study was carried out with 45 patients (29 male and 16 female), with ages ranging from 11 to 48 years. All subjects were from an area to which leishmaniasis is endemic, Corte de Pedra (Bahia, Brazil), and the duration of the illness was </=30 days. The patients were classified as positive or negative for IgE serology in enzyme-linked immunosorbent assay with leishmanial antigens. IgE antibodies were detected in 18 patients (optical density, 0.421 +/- 0.30; 95% confidence interval, 0.27 to 0.57), and only 3 (17%) had more than one ulcer. In this group the diameter of Montenegro's reaction was 18 +/- 12.2 mm. In the group with negative IgE serology, 11 of 27 patients (48%) presented two or more cutaneous ulcers, and the mean of the skin test result was 9 +/- 6.9 mm. There was a positive correlation between IgE antibody levels and Montenegro's reaction size and an inverse correlation between IgE antileishmanial antibodies and the number of skin ulcers. The presence of antileishmanial IgE antibodies in cutaneous leishmaniasis may be a result of immunoregulatory events with clinical implications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777837      PMCID: PMC119873          DOI: 10.1128/cdli.9.1.101-104.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

Review 1.  Cytokines and T cells in host defense.

Authors:  C A Hunter; S L Reiner
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

2.  IL-13 is a susceptibility factor for Leishmania major infection.

Authors:  D J Matthews; C L Emson; G J McKenzie; H E Jolin; J M Blackwell; A N McKenzie
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.

Authors:  K Anam; F Afrin; D Banerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; N Ali
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis.

Authors:  P N Rocha; R P Almeida; O Bacellar; A R de Jesus; D C Filho; A C Filho; A Barral; R L Coffman; E M Carvalho
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

7.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

Authors:  E M Carvalho; W D Johnson; E Barreto; P D Marsden; J L Costa; S Reed; H Rocha
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

10.  Characterization of the cellular immune response in American cutaneous leishmaniasis.

Authors:  M Castes; A Agnelli; O Verde; A J Rondón
Journal:  Clin Immunol Immunopathol       Date:  1983-05
View more
  4 in total

1.  ELISA-based evaluation of antibody response to Leishmania in a region endemic for cutaneous leishmaniasis.

Authors:  Sachee Bhanu Piyasiri; Thisum Nilakshi Samaranayake; Hermali Silva; Nuwani Harshamali Manamperi; Nadira Darshani Karunaweera
Journal:  Parasite Immunol       Date:  2022-08-03       Impact factor: 2.206

2.  Comparative immune study on cutaneous leishmaniasis patients with single and multiple sores.

Authors:  Ban Noori Al-Qadhi; Israa Salim Musa; Yassir Mustafa Kamal Al-Mulla Hummadi
Journal:  J Parasit Dis       Date:  2013-11-21

3.  IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway.

Authors:  Ioannis Vouldoukis; Dominique Mazier; Daniel Moynet; Denis Thiolat; Denis Malvy; M Djavad Mossalayi
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

4.  Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against Leishmania mexicana Infection.

Authors:  Bernard Ong'ondo Osero; Zama Cele; Raphael Taiwo Aruleba; Rebeng A Maine; Mumin Ozturk; Manfred B Lutz; Frank Brombacher; Ramona Hurdayal
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.